التفاصيل البيبلوغرافية
| العنوان: |
Findings from Tor Vergata University of Rome Broaden Understanding of Atherosclerosis (Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?). |
| المصدر: |
Clinical Trials Week; 12/12/2023, p298-298, 1p |
| مصطلحات موضوعية: |
GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, ATHEROSCLEROSIS, WEIGHT loss, GLUCAGON-like peptide 1 |
| مصطلحات جغرافية: |
ROME |
| مستخلص: |
A recent report from Tor Vergata University of Rome explores the role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the treatment of atherosclerosis. Atherosclerosis is a chronic inflammatory disease characterized by the buildup of lipids and inflammatory cells in the arteries. The researchers found that GLP-1RAs have shown promising results in reducing atherosclerotic events and mortality in patients with type 2 diabetes. Preclinical studies suggest that GLP-1RAs may modulate the immune response and affect pathways involved in plaque development and progression. Further clinical trials are needed to investigate the atheroprotective effects of GLP-1RAs. [Extracted from the article] |
|
Copyright of Clinical Trials Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
